BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 21864933)

  • 1. Confirmation of the role of diabetes in the local recurrence of surgically resected non-small cell lung cancer.
    Varlotto J; Medford-Davis LN; Recht A; Flickinger J; Schaefer E; Shelkey J; Lazar M; Campbell D; Nikolov M; Decamp MM
    Lung Cancer; 2012 Mar; 75(3):381-90. PubMed ID: 21864933
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Varying recurrence rates and risk factors associated with different definitions of local recurrence in patients with surgically resected, stage I nonsmall cell lung cancer.
    Varlotto JM; Recht A; Flickinger JC; Medford-Davis LN; Dyer AM; DeCamp MM
    Cancer; 2010 May; 116(10):2390-400. PubMed ID: 20225332
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic predictors in non-small cell lung cancer patients undergoing intentional segmentectomy.
    Koike T; Koike T; Yamato Y; Yoshiya K; Toyabe S
    Ann Thorac Surg; 2012 Jun; 93(6):1788-94. PubMed ID: 22560265
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Risk factors of recurrence in resected stage I non-small cell lung cancer].
    Kita H; Koshiishi Y; Masui K; Fujita A; Ootsuka K; Furuyashiki G; Nakazato Y; Takei H; Goya T
    Kyobu Geka; 2007 Sep; 60(10):883-7. PubMed ID: 17877005
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Failure rates and patterns of recurrence in patients with resected N1 non-small-cell lung cancer.
    Varlotto JM; Medford-Davis LN; Recht A; Flickinger JC; Schaefer E; DeCamp MM
    Int J Radiat Oncol Biol Phys; 2011 Oct; 81(2):353-9. PubMed ID: 20732754
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Local failure after complete resection of N0-1 non-small cell lung cancer.
    Saynak M; Veeramachaneni NK; Hubbs JL; Nam J; Qaqish BF; Bailey JE; Chung W; Marks LB
    Lung Cancer; 2011 Feb; 71(2):156-65. PubMed ID: 20615576
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A clinical model to estimate recurrence risk in resected stage I non-small cell lung cancer.
    Goodgame B; Viswanathan A; Miller CR; Gao F; Meyers B; Battafarano RJ; Patterson A; Cooper J; Guthrie TJ; Bradley J; Pillot G; Govindan R
    Am J Clin Oncol; 2008 Feb; 31(1):22-8. PubMed ID: 18376223
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An association between preoperative anemia and decreased survival in early-stage non-small-cell lung cancer patients treated with surgery alone.
    Yovino S; Kwok Y; Krasna M; Bangalore M; Suntharalingam M
    Int J Radiat Oncol Biol Phys; 2005 Aug; 62(5):1438-43. PubMed ID: 16029805
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Impact of visceral pleural invasion on the prognosis of stage Ib non-small cell lung cancer].
    Su XD; Long H; Wang X; Fu JH; He JH; Lin P; Zhang LJ; Ma GW
    Zhonghua Zhong Liu Za Zhi; 2008 May; 30(5):368-71. PubMed ID: 18953838
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term outcomes of en bloc resection of non-small cell lung cancer invading the thoracic inlet and spine.
    Fadel E; Missenard G; Court C; Mercier O; Mussot S; Fabre D; Dartevelle P
    Ann Thorac Surg; 2011 Sep; 92(3):1024-30; discussion 1030. PubMed ID: 21871294
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tumor recurrence after complete resection for non-small cell lung cancer.
    Taylor MD; Nagji AS; Bhamidipati CM; Theodosakis N; Kozower BD; Lau CL; Jones DR
    Ann Thorac Surg; 2012 Jun; 93(6):1813-20; discussion 1820-1. PubMed ID: 22542070
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Surgical resection for multifocal (T4) non-small cell lung cancer: is the T4 designation valid?
    Port JL; Korst RJ; Lee PC; Kansler AL; Kerem Y; Altorki NK
    Ann Thorac Surg; 2007 Feb; 83(2):397-400. PubMed ID: 17257959
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stage IB nonsmall cell lung cancers: are they all the same?
    Jones DR; Daniel TM; Denlinger CE; Rundall BK; Smolkin ME; Wick MR
    Ann Thorac Surg; 2006 Jun; 81(6):1958-62; discussion 1962. PubMed ID: 16731113
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Results of primary surgery with T4 non-small cell lung cancer during a 25-year period in a single center: the benefit is worth the risk.
    Yildizeli B; Dartevelle PG; Fadel E; Mussot S; Chapelier A
    Ann Thorac Surg; 2008 Oct; 86(4):1065-75; discussion 1074-5. PubMed ID: 18805134
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Frequency of local recurrence following segmentectomy of stage IA non-small cell lung cancer is influenced by segment localisation and width of resection margins--implications for patient selection for segmentectomy.
    Sienel W; Stremmel C; Kirschbaum A; Hinterberger L; Stoelben E; Hasse J; Passlick B
    Eur J Cardiothorac Surg; 2007 Mar; 31(3):522-7; discussion 527-8. PubMed ID: 17229574
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term survival and recurrence in patients with resected non-small cell lung cancer 1 cm or less in size.
    Lee PC; Korst RJ; Port JL; Kerem Y; Kansler AL; Altorki NK
    J Thorac Cardiovasc Surg; 2006 Dec; 132(6):1382-9. PubMed ID: 17140961
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Outcomes of sublobar resection versus lobectomy for stage I non-small cell lung cancer: a 13-year analysis.
    El-Sherif A; Gooding WE; Santos R; Pettiford B; Ferson PF; Fernando HC; Urda SJ; Luketich JD; Landreneau RJ
    Ann Thorac Surg; 2006 Aug; 82(2):408-15; discussion 415-6. PubMed ID: 16863738
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical and molecular predictors of recurrence in stage I non-small cell lung cancer.
    Starnes SL; Pathrose P; Wang J; Succop P; Morris JC; Bridges J; Kupert EY; Anderson M
    Ann Thorac Surg; 2012 May; 93(5):1606-12. PubMed ID: 22440368
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Local failure in resected N1 lung cancer: implications for adjuvant therapy.
    Higgins KA; Chino JP; Berry M; Ready N; Boyd J; Yoo DS; Kelsey CR
    Int J Radiat Oncol Biol Phys; 2012 Jun; 83(2):727-33. PubMed ID: 22208965
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Outcomes of stereotactic ablative radiotherapy in patients with potentially operable stage I non-small cell lung cancer.
    Lagerwaard FJ; Verstegen NE; Haasbeek CJ; Slotman BJ; Paul MA; Smit EF; Senan S
    Int J Radiat Oncol Biol Phys; 2012 May; 83(1):348-53. PubMed ID: 22104360
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.